CXCR1 and idiopathic pulmonary fibrosis: These signaling molecules act on the CXCR1 and CXCR2 receptor, as well as regulate the expression of cytokines from the interleukin family, central to the pathogenesis of fibrotic and inflammatory lung diseases such as IPF and acute respiratory distress syndrome (3, 8, 36, 43).